Dacinostat | 达西司特 | LAQ824 | Autophagy Inducer | AmBeed-信号通路专用抑制剂

首页 / / / 组蛋白去乙酰化酶 / Dacinostat

达诺司他 /Dacinostat {[allProObj[0].p_purity_real_show]}

货号：A226377 同义名： 达西司特 / LAQ824;NVP-LAQ824

Dacinostat is a HDAC inhibitor with IC50 of 32 nM which can activate the p21 promoter.

Dacinostat 化学结构
CAS号：404951-53-7

Dacinostat 3D分子结构
CAS号：404951-53-7

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Dacinostat 纯度/质量文件产品仅供科研

货号：A226377 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Cell, 2024, 101755. Ambeed. [ A399663 ]; • EMBO J., 2024. Ambeed. [ A295334 ]; • JMC, 2024, 67(20): 18265-18289. Ambeed. [ A538667 , A341145 , A117430 , A172297 ]; • JMC, 2024. Ambeed. [ A210558 , A1518164 ]; • Cell Death Discov., 2024, 10, 436. Ambeed. [ A384235 ]; 更多 >

组蛋白去乙酰化酶亚型比较

产品名称	HD1 ↓ ↑	HD2 ↓ ↑	HDAC ↓ ↑	HDAC1 ↓ ↑	HDAC10 ↓ ↑	HDAC11 ↓ ↑	HDAC2 ↓ ↑	HDAC3 ↓ ↑	HDAC4 ↓ ↑	HDAC5 ↓ ↑	HDAC6 ↓ ↑	HDAC7 ↓ ↑	HDAC8 ↓ ↑	HDAC9 ↓ ↑	其他靶点	纯度
Givinostat HCl monohydrate	++++ HD1-A, IC50: 16 nM HD1-B, IC50: 7.5 nM	+++ HD2, IC50: 10 nM														99%+
MC1568	++ HD1-A (Maize), IC50: 100 nM HD1-B (Maize), IC50: 3.4 μM															96%
Trichostatin A			++++ HDAC, IC50: ~1.8 nM													99%+
Scriptaid			✔													99%+
Valproic acid sodium			✔												Autophagy	97%
AR-42			+++ HDAC, IC50: 30 nM													99%+
Dacinostat			+++ HDAC, IC50: 32 nM													98+%
CUDC-101			++++ HDAC, IC50: 4.4 nM	++++ HDAC1, IC50: 4.5 nM	+++ HDAC10, IC50: 26.1 nM		+++ HDAC2, IC50: 12.6 nM	++++ HDAC3, IC50: 9.1 nM	+++ HDAC4, IC50: 13.2 nM	+++ HDAC5, IC50: 11.4 nM	++++ HDAC6, IC50: 5.1 nM	+ HDAC7, IC50: 373 nM	++ HDAC8, IC50: 79.8 nM	++ HDAC9, IC50: 67.2 nM	HER2,EGFR	99%+
M344			++ HDAC, IC50: 100 nM													99%+
Splitomicin			+ Sir2p, IC50: 60 μM													95%
Panobinostat			++++ HDAC (MOLT-4 cells), IC50: 5 nM HDAC (Reh cells), IC50: 20 nM													98%
Sodium 4-Phenylbutyrate			✔													98%
Vorinostat			+++ HDAC, IC50: ~10 nM													98%
Curcumin			✔												NF-κB,Nrf2	98%
Belinostat			+++ HDAC, IC50: 27 nM													98%
RG-2833				++ HDAC1, Ki: 32 nM				++ HDAC3, Ki: 5 nM								98%
Valproic acid				+ HDAC1, IC50: 0.4 mM												98%
BG45				+ HDAC1, IC50: 2 μM			+ HDAC2, IC50: 2.2 μM	+ HDAC3, IC50: 289 nM								99%+
Entinostat				+ HDAC1, IC50: 0.51 μM				+ HDAC3, IC50: 1.7 μM								98%
Resminostat				+++ HDAC1, IC50: 42.5 nM				++ HDAC3, IC50: 50.1 nM			++ HDAC6, IC50: 71.8 nM					98+%
Romidepsin				+++ HDAC1, IC50: 36 nM			+++ HDAC2, IC50: 47 nM									99%+
Parthenolide				✔											NF-κB,p53	97% HPLC
Tacedinaline				+ HDAC1, IC50: 0.9 μM			+ HDAC2, IC50: 0.9 μM	+ HDAC3, IC50: 1.2 μM								98%
Mocetinostat				++ HDAC1, IC50: 0.15 μM		+ HDAC11, IC50: 0.59 μM	+ HDAC2, IC50: 0.29 μM	+ HDAC3, IC50: 1.66 μM								98%
WT-161				++++ HDAC1, IC50: 8.35 nM			+++ HDAC2, IC50: 15.4 nM				++++ HDAC6, IC50: 0.4 nM					99%+
Fimepinostat				++++ HDAC1, IC50: 1.7 nM	++++ HDAC10, IC50: 2.8 nM	++++ HDAC11, IC50: 5.4 nM	++++ HDAC2, IC50: 5.0 nM	++++ HDAC3, IC50: 1.8 nM			+++ HDAC6, IC50: 27 nM					99%+
Tucidinostat				++ HDAC1, IC50: 95 nM	++ HDAC10, IC50: 78 nM		++ HDAC2, IC50: 160 nM	++ HDAC3, IC50: 67 nM								99%+
Santacruzamate A							++++ HDAC2, IC50: 119 pM									99%+
(E,E)-RGFP966								++ HDAC3, IC50: 80 nM								99%+
LMK-235									+++ HDAC4, IC50: 11.9 nM	++++ HDAC5, IC50: 4.2 nM						99%+
Tasquinimod									✔							99%+
CAY10603											++++ HDAC6, IC50: 2 pM					98%
Tubastatin A											+++ HDAC6, IC50: 15 nM					98%
Tubacin											++++ HDAC6, IC50: 4 nM					99%+
ACY-738											++++ HDAC6, IC50: 1.7 nM					99%+
Nexturastat A											++++ HDAC6, IC50: 5 nM					99%+
BRD73954											+++ HDAC6, IC50: 36 nM		++ HDAC8, IC50: 120 nM			98%
Tubastatin A HCl											+++ HDAC6, IC50: 15 nM		+ HDAC8, IC50: 854 nM			98%
PCI-34051													+++ HDAC8, IC50: 10 nM			99%+
Ricolinostat				++ HDAC1, IC50: 58 nM			++ HDAC2, IC50: 48 nM	++ HDAC3, IC50: 51 nM			++++ HDAC6, IC50: 4.7 nM		++ HDAC8, IC50: 100 nM			99%+
Droxinostat								+ HDAC3, IC50: 16.9 μM			+ HDAC6, IC50: 2.47 μM		+ HDAC8, IC50: 1.46 μM			99%+
Abexinostat				++++ HDAC1, Ki: 7 nM	+++ HDAC10, IC50: 24 nM		+++ HDAC2, Ki: 19 nM	++++ HDAC3/SMRT, Ki: 8.2 nM			+++ HDAC6, Ki: 17 nM		+ HDAC8, IC50: 280 nM			98%+
Citarinostat				+++ HDAC1, IC50: 35 nM			+++ HDAC2, IC50: 45 nM	+++ HDAC3, IC50: 46 nM			++++ HDAC6, IC50: 2.6 nM		++ HDAC8, IC50: 137 nM			99%+
HPOB				+ HDAC1, IC50: 2.9 μM	+ HDAC10, IC50: 3.0 μM		+ HDAC2, IC50: 4.4 μM	+ HDAC3, IC50: 1.7 μM			++ HDAC6, IC50: 56 nM		+ HDAC8, IC50: 2.8 μM			97%
Quisinostat 2HCl				++++ HDAC1, IC50: 0.11 nM	++++ HDAC10, IC50: 0.46 nM	++++ HDAC11, IC50: 0.37 nM	++++ HDAC2, IC50: 0.33 nM	++++ HDAC3, IC50: 4.86 nM	++++ HDAC4, IC50: 0.64 nM	++++ HDAC5, IC50: 3.69 nM			++++ HDAC8, IC50: 4.26 nM			99+%
Domatinostat				+ HDAC1, IC50: 1.20 μM	+ HDAC10, IC50: 21 μM	+ HDAC11, IC50: 9.7 μM	+ HDAC2, IC50: 1.12 μM	+ HDAC3, IC50: 0.57 μM		+ HDAC5, IC50: 11.3 μM				+ HDAC9, IC50: 50 μM		99%+
TMP269									++ HDAC4, IC50: 157 nM	++ HDAC5, IC50: 97 nM		+++ HDAC7, IC50: 43 nM		+++ HDAC9, IC50: 23 nM		99%+
Pracinostat				++ HDAC1, IC50: 49 nM	+++ HDAC10, IC50: 40 nM	++ HDAC11, IC50: 93 nM	++ HDAC2, IC50: 96 nM	+++ HDAC3, IC50: 43 nM	++ HDAC4, IC50: 56 nM	+++ HDAC5, IC50: 47 nM	+ HDAC6, IC50: 1.008 μM	++ HDAC7, IC50: 137 nM	++ HDAC8, IC50: 140 nM	++ HDAC9, IC50: 70 nM		99%+
TMP195									++ HDAC4, Ki: 59 nM	++ HDAC5, Ki: 60 nM		+++ HDAC7, Ki: 26 nM		+++ HDAC9, Ki: 15 nM		99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Dacinostat 生物活性

靶点	HDAC HDAC, IC50:32 nM
描述	Dacinostat is a highly potent HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.

Dacinostat 细胞研究

细胞系	浓度	检测类型	检测时间	活动说明	数据源
786-0 cells		Proliferation assay		Antiproliferative activity against human 786-0 cells by SRB assay, GI50=2.38 μM	21621883
A498 cells		Proliferation assay		Antiproliferative activity against human A498 cells by SRB assay, GI50=1.11 μM	21621883
A498 cells		Cytotoxicity assay		Cytotoxicity against human A498 cells, LC50=5.88 μM	21621883
A549 cells		Proliferation assay		Antiproliferative activity against human A549 cells by SRB assay, GI50=1.09 μM	21621883

Dacinostat 参考文献

[1]Wang H, Cheng F, et al. Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10. J Immunol. 2011 Apr 1;186(7):3986-96.

[2]Atadja P, Gao L, et al. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824. Cancer Res. 2004 Jan 15;64(2):689-95.

Dacinostat 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

2.64mL

0.53mL

0.26mL

13.18mL

2.64mL

1.32mL

26.35mL

5.27mL

2.64mL

Dacinostat 技术信息

CAS号	404951-53-7
分子式	C₂₂H₂₅N₃O₃
分子量	379.452

别名	达西司特 ;LAQ824;NVP-LAQ824
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,2-8°C

溶解度

DMSO: 45 mg/mL(118.59 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

5%DMSO+40%PEG300+5%Tween80+50%water 15 mg/mL

细胞研究

细胞系	浓度	检测类型	检测时间	活动说明	数据源

786-0 cells		Proliferation assay		Antiproliferative activity against human 786-0 cells by SRB assay, GI50=2.38 μM	21621883
A498 cells		Proliferation assay		Antiproliferative activity against human A498 cells by SRB assay, GI50=1.11 μM	21621883
A498 cells		Cytotoxicity assay		Cytotoxicity against human A498 cells, LC50=5.88 μM	21621883
A549 cells		Proliferation assay		Antiproliferative activity against human A549 cells by SRB assay, GI50=1.09 μM	21621883
ACHN cells		Proliferation assay		Antiproliferative activity against human ACHN cells by SRB assay, GI50=1.1 μM	21621883
BT549 cells		Proliferation assay		Antiproliferative activity against human BT549 cells by SRB assay, GI50=6.04 μM	21621883
Caki1 cells		Proliferation assay		Antiproliferative activity against human Caki1 cells by SRB assay, GI50=0.619 μM	21621883
Caki1 cells		Cytotoxicity assay		Cytotoxicity against human Caki1 cells, LC50=5.79 μM	21621883
CCRF-CEM cells		Proliferation assay		Antiproliferative activity against human CCRF-CEM cells by SRB assay, GI50=0.251 μM	21621883
CHO cells		Function assay		Inhibition of human ERG expressed in CHO cells by automated patch clamp electrophysiology assay, IC50=12.2 μM	20205394
COLO205 cells		Proliferation assay		Antiproliferative activity against human COLO205 cells by SRB assay, GI50=1.08 μM	21621883
DU145 cells		Proliferation assay		Antiproliferative activity against human DU145 cells by SRB assay, GI50=29.9 μM	21621883
EKVX cells		Proliferation assay		Antiproliferative activity against human EKVX cells by SRB assay, GI50=1.75 μM	21621883
H1299		Growth inhibition assay		Inhibitory activity against H1299 human lung carcinoma cell growth, IC50=0.15 μM	14521422
H1299 cells		Proliferation assay		Antiproliferative activity against human H1299 cells by MTS assay, IC50=0.161 μM	20205394
H1299 cells		Proliferation assay		Antiproliferative activity against human H1299 cells, IC50=0.1 μM	21650221
H460 cells		Growth inhibition assay	48 h	Growth inhibition of human H460 cells after 48 hrs by SRB assay, IC50=0.07 μM	21073160
HCT116		Growth inhibition assay		Inhibitory activity against HCT116 human colon cell growth, IC50=0.01 μM	14521422
HCT116		Cytotoxicity assay		Cytotoxicity against human HCT116 cells by MTT assay, IC50=0.05 μM	17941625
HCT116 cells		Proliferation assay		Antiproliferative activity against human HCT116 cells by MTS assay, IC50=0.013 μM	20205394
HCT116 cells		Growth inhibition assay	48 h	Growth inhibition of human HCT116 cells after 48 hrs by SRB assay, IC50=0.018 μM	21073160
HCT116 cells		Proliferation assay		Antiproliferative activity against human HCT116 cells by SRB assay, GI50=0.347 μM	21621883
HCT116 cells		Proliferation assay		Antiproliferative activity against human HCT116 cells, IC50=0.019 μM	21742496
HCT116 cells		Proliferation assay		Antiproliferative activity against human HCT116 cells assessed as growth inhibition, IC50=0.019 μM	21650221
HCT116 cells		Proliferation assay		Inhibitory concentration against HCT116 cells proliferation, IC50=0.01 μM	14613312
HCT15 cells		Proliferation assay		Antiproliferative activity against human HCT15 cells by SRB assay, GI50=2.07 μM	21621883
HEK293 cells		Function assay		Inhibition of HDAC1 in HEK293 cells, IC50=0.0026 μM	18308563
HeLa cells	0.3 μM	Function assay	16 h	Inhibition of HDAC4-mediated repression of MEF2-dependent transcription in HeLa cells at 0.3 uM after 16 hrs by luciferase reporter gene assay	17956988
HL-60(TB) cells		Proliferation assay		Antiproliferative activity against human HL-60(TB) cells by SRB assay, GI50=0.249 μM	21621883
HOP62 cells		Proliferation assay		Antiproliferative activity against human HOP62 cells by SRB assay, GI50=0.502 μM	21621883
HOP92 cells		Proliferation assay		Antiproliferative activity against human HOP92 cells by SRB assay, GI50=0.199 μM	21621883
Hs 578T cells		Proliferation assay		Antiproliferative activity against human Hs 578T cells by SRB assay, GI50=5.82 μM	21621883
HT-29 cells		Proliferation assay		Antiproliferative activity against human HT-29 cells by SRB assay, GI50=0.566 μM	21621883
human mammary epithelial cells		Cytotoxicity assay		Cytotoxicity against human mammary epithelial cells by MTT assay, IC50=1 μM	17941625
IGROV1 cells		Proliferation assay		Antiproliferative activity against human IGROV1 cells by SRB assay, GI50=0.187 μM	21621883
IGROV1 cells		Cytotoxicity assay		Cytotoxicity against human IGROV1 cells, LC50=48.9 μM	21621883
K562 cells		Proliferation assay		Antiproliferative activity against human K562 cells by SRB assay, GI50=0.55 μM	21621883
KM12 cells		Proliferation assay		Antiproliferative activity against human KM12 cells by SRB assay, GI50=1.04 μM	21621883
KM12 cells		Cytotoxicity assay		Cytotoxicity against human KM12 cells, LC50=29.9 μM	21621883
LOXIMVI cells		Proliferation assay		Antiproliferative activity against human LOXIMVI cells by SRB assay, GI50=1.08 μM	21621883
LOXIMVI cells		Cytotoxicity assay		Cytotoxicity against human LOXIMVI cells, LC50=6.04 μM	21621883
M14 cells		Proliferation assay		Antiproliferative activity against human M14 cells by SRB assay, GI50=0.849 μM	21621883
MALME-3M cells		Proliferation assay		Antiproliferative activity against human MALME-3M cells by SRB assay, GI50=0.461 μM	21621883
MCF7 cells		Proliferation assay		Antiproliferative activity against human MCF7 cells by SRB assay, GI50=6.91 μM	21621883
MDA-MB-231 cells		Proliferation assay		Antiproliferative activity against human MDA-MB-231 cells by SRB assay, GI50=31.7 μM	21621883
MDA-MB-435 cells		Proliferation assay		Antiproliferative activity against human MDA-MB-435 cells by SRB assay, GI50=0.537 μM	21621883
MDA-MB-435 cells		Cytotoxicity assay		Cytotoxicity against human MDA-MB-435 cells, LC50=28.8 μM	21621883
MDA-MB-468 cells		Proliferation assay		Antiproliferative activity against human MDA-MB-468 cells by SRB assay, GI50=5.88 μM	21621883
MOLT4 cells		Proliferation assay		Antiproliferative activity against human MOLT4 cells by SRB assay, GI50=0.311 μM	21621883
NCI/ADR-RES cells		Proliferation assay		Antiproliferative activity against human NCI/ADR-RES cells by SRB assay, GI50=0.18 μM	21621883
NCI-H226 cells		Proliferation assay		Antiproliferative activity against human NCI-H226 cells by SRB assay, GI50=1.41 μM	21621883
NCI-H226 cells		Cytotoxicity assay		Cytotoxicity against human NCI-H226 cells, LC50=20 μM	21621883
NCI-H23 cells		Proliferation assay		Antiproliferative activity against human NCI-H23 cells by SRB assay, GI50=1.5 μM	21621883
NCI-H322M cells		Proliferation assay		Antiproliferative activity against human NCI-H322M cells by SRB assay, GI50=2.26 μM	21621883
NCI-H460 cells		Proliferation assay		Antiproliferative activity against human NCI-H460 cells by SRB assay, GI50=0.7 μM	21621883
OVCAR3 cells		Proliferation assay		Antiproliferative activity against human OVCAR3 cells by SRB assay, GI50=1.11 μM	21621883
OVCAR4 cells		Proliferation assay		Antiproliferative activity against human OVCAR4 cells by SRB assay, GI50=3.21 μM	21621883
OVCAR5 cells		Proliferation assay		Antiproliferative activity against human OVCAR5 cells by SRB assay, GI50=0.26 μM	21621883
OVCAR5 cells		Cytotoxicity assay		Cytotoxicity against human OVCAR5 cells, LC50=38.9 μM	21621883
OVCAR8 cells		Proliferation assay		Antiproliferative activity against human OVCAR8 cells by SRB assay, GI50=0.45 μM	21621883
PC3 cells		Proliferation assay		Antiproliferative activity against human PC3 cells by SRB assay, GI50=20 μM	21621883
RPMI8226 cells		Proliferation assay		Antiproliferative activity against human RPMI8226 cells by SRB assay, GI50=0.523 μM	21621883
RXF393 cells		Proliferation assay		Antiproliferative activity against human RXF393 cells by SRB assay, GI50=0.01 μM	21621883
RXF393 cells		Cytotoxicity assay		Cytotoxicity against human RXF393 cells, LC50=15.3 μM	21621883
SF268 cells		Proliferation assay		Antiproliferative activity against human SF268 cells by SRB assay, GI50=1.53 μM	21621883
SF295 cells		Proliferation assay		Antiproliferative activity against human SF295 cells by SRB assay, GI50=0.743 μM	21621883
SF295 cells		Cytotoxicity assay		Cytotoxicity against human SF295 cells, LC50=6.91 μM	21621883
SF539 cells		Proliferation assay		Antiproliferative activity against human SF539 cells by SRB assay, GI50=0.965 μM	21621883
SK-MEL-28 cells		Proliferation assay		Antiproliferative activity against human SK-MEL-28 cells by SRB assay, GI50=0.993 μM	21621883
SK-MEL-28 cells		Cytotoxicity assay		Cytotoxicity against human SK-MEL-28 cells, LC50=31.9 μM	21621883
SK-MEL-5 cells		Proliferation assay		Antiproliferative activity against human SK-MEL-5 cells by SRB assay, GI50=0.271 μM	21621883
SK-MEL-5 cells		Cytotoxicity assay		Cytotoxicity against human SK-MEL-5 cells, LC50=4.02 μM	21621883
SKOV3 cells		Proliferation assay		Antiproliferative activity against human SKOV3 cells by SRB assay, GI50=0.524 μM	21621883
SKOV3 cells		Cytotoxicity assay		Cytotoxicity against human SKOV3 cells, LC50=28.5 μM	21621883
SN12C cells		Proliferation assay		Antiproliferative activity against human SN12C cells by SRB assay, GI50=3.92 μM	21621883
SNB19 cells		Proliferation assay		Antiproliferative activity against human SNB19 cells by SRB assay, GI50=1.53 μM	21621883
SNB19 cells		Cytotoxicity assay		Cytotoxicity against human SNB19 cells, LC50=31.7 μM	21621883
SNB75 cells		Proliferation assay		Antiproliferative activity against human SNB75 cells by SRB assay, GI50=0.318 μM	21621883
SR cells		Proliferation assay		Antiproliferative activity against human SR cells by SRB assay, GI50=2.99 μM	21621883
SW620 cells		Proliferation assay		Antiproliferative activity against human SW620 cells by SRB assay, GI50=0.478 μM	21621883
T47D cells		Proliferation assay		Antiproliferative activity against human T47D cells by SRB assay, GI50=28.8 μM	21621883
TK10 cells		Proliferation assay		Antiproliferative activity against human TK10 cells by SRB assay, GI50=0.444 μM	21621883
U251 cells		Proliferation assay		Antiproliferative activity against human U251 cells by SRB assay, GI50=0.773 μM	21621883
U251 cells		Cytotoxicity assay		Cytotoxicity against human U251 cells, LC50=5.82 μM	21621883
UACC257 cells		Proliferation assay		Antiproliferative activity against human UACC257 cells by SRB assay, GI50=0.393 μM	21621883
UACC257 cells		Cytotoxicity assay		Cytotoxicity against human UACC257 cells, LC50=44.8 μM	21621883
UACC62 cells		Proliferation assay		Antiproliferative activity against human UACC62 cells by SRB assay, GI50=0.379 μM	21621883
UACC62 cells		Cytotoxicity assay		Cytotoxicity against human UACC62 cells, LC50=6.39 μM	21621883
UO31 cells		Proliferation assay		Antiproliferative activity against human UO31 cells by SRB assay, GI50=0.452 μM	21621883

达诺司他 /Dacinostat {[allProObj[0].p_purity_real_show]}

Dacinostat 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Dacinostat 质控信息

Dacinostat 生物活性

Dacinostat 细胞研究

Dacinostat 参考文献

Dacinostat 实验方案

Dacinostat 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

达诺司他 /Dacinostat {[allProObj[0].p_purity_real_show]}

Dacinostat 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Dacinostat 质控信息

Dacinostat 生物活性

Dacinostat 细胞研究

Dacinostat 参考文献

Dacinostat 实验方案

Dacinostat 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Dacinostat 纯度/质量文件产品仅供科研